Article Text
Abstract
Paraneoplastic demyelination is a rare disorder of the central nervous system. We describe a 60-year-old man with tumefactive demyelination who had an underlying retroperitoneal germ cell cancer. He presented with visuospatial problems and memory loss and had a visual field defect. His MRI was interpreted as a glioma but stereotactic biopsy showed active demyelination. Investigation for multiple sclerosis was negative but CT imaging showed retroperitoneal lymphadenopathy, and nodal biopsy confirmed a combined germ cell cancer. He responded poorly to corticosteroid treatment, and his visual field defect progressed. However, 6 months after plasma exchange and successful chemotherapy, he has partially improved clinically and radiographically. Tumefactive demyelination is typically associated with multiple sclerosis but may be paraneoplastic. It is important to recognise paraneoplastic tumefactive demyelination early, as the neurological outcome relies on treating the associated malignancy.
- germ cell cancer
- seminoma
- paraneoplastic syndromes, nervous system
- demyelination
- tumefactive
Statistics from Altmetric.com
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information:
Read the full text or download the PDF:
Other content recommended for you
- Tumefactive demyelination: an approach to diagnosis and management
- CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
- Tumefactive demyelination associated with systemic lupus erythematosus
- Tumefactive demyelination presenting during bevacizumab treatment
- A follow up study of patients with paraneoplastic neurological disease in the United Kingdom
- Multiple sclerosis deep grey matter: the relation between demyelination, neurodegeneration, inflammation and iron
- Demyelinating diseases
- Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia
- The corpus callosum in the diagnosis of multiple sclerosis and other CNS demyelinating and inflammatory diseases
- Myelin injury without astrocytopathy in neuroinflammatory disorders with MOG antibodies